Tóvári, J.; Vári-Mező, D.; Surguta, S.E.; Ladányi, A.; Kigyós, A.; Cserepes, M.
Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets. Cells 2023, 12, 1919.
https://doi.org/10.3390/cells12141919
AMA Style
Tóvári J, Vári-Mező D, Surguta SE, Ladányi A, Kigyós A, Cserepes M.
Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets. Cells. 2023; 12(14):1919.
https://doi.org/10.3390/cells12141919
Chicago/Turabian Style
Tóvári, József, Diána Vári-Mező, Sára Eszter Surguta, Andrea Ladányi, Attila Kigyós, and Mihály Cserepes.
2023. "Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets" Cells 12, no. 14: 1919.
https://doi.org/10.3390/cells12141919
APA Style
Tóvári, J., Vári-Mező, D., Surguta, S. E., Ladányi, A., Kigyós, A., & Cserepes, M.
(2023). Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets. Cells, 12(14), 1919.
https://doi.org/10.3390/cells12141919